HempFusion is leading health and wellness CBD company and I had a great time interviewing their CEO Jason Mitchell. Their proprietary portfolio of products includes a suite of CBD solutions and Probulin probiotics.
Jason and I discussed his background in the space, the scope of the CBD opportunity and he shares who is using hemp-based products. We also cover why 2021 has been a challenging year for cannabis-related stocks and some reasons for optimism in the New Year. Finally, Jason leaves us with two goals for HempFusion in 2022.
HempFusion is the only dedicated CBD exposure in the highly regarded $MSOS ETF. The stock is down over 90% in the last year, largely due to political stalemates and slow-moving regulatory changes. With some progress in ’22, it could be due for a rebound.
Click here for the full interview.